Quote:
Originally Posted by chadwick4eva
I too am long JPM as well and think MS is one of the premiere large wealth management firms as well. Both solid choices in financials. However, I'm a bit concerned about where they are sitting at in terms of the p/b value relative to historic levels. Here are the p/b ratios over time for both:
https://www.macrotrends.net/stocks/c...ase/price-book
https://www.macrotrends.net/stocks/c...ley/price-book
In both of these cases the run on both stocks is a bit concerning. We are looking at a multidecade high in both names for the p/b ratio. Personally I feel that now is the time to trim in financials as much of the sector has run red hot so far this year. JPM is one of my best yielding stocks, however, and I don't really want to trim as I have multi decade time horizon.
The only subset of the financials I feel differently about is many insurers- I feel that a lot of the health insurers (UNH, ANTM, HUM), and property/casualty insurance companies (ALL, PGR, AFL, etc.) are actually reasonably priced based on historical trading levels. For the most part these companies also have good fundamental trends and strong histories of driving shareholder value with buybacks and dividends. While these companies have had a solid little run in the past few months, they have not experienced the same level of gains that a lot of the major bank stocks/ capital markets stocks have enjoyed. I made a post on it a while ago but from a Free Cash Flow perspective many of these businesses are also total monsters. There is a CFA youtuber I like who recently did a deep dive on AllState and by his modeling he thought they should provide a 20% IRR the next 5-10 years. Here's his video analysis:
https://www.youtube.com/watch?v=PjgxF8dFAf4 |
Holding JPM for the dividend yield is good. MS and GS are dogs.
I keep that out of the portfolio due to long-term drama with those firms on the institutional side lol.
//opinions absolutely not advice or relevant positions\\